Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT00769379
Protocol Number
NGDC-005
Phase
III
Management Group
Northeast Georgia Diagnostic Clinic
Oncology Group
Breast Oncology Group
Disease Sites
Breast
Sponsor Protocol
NSABP-B-43
Principal Investigator
Richard LoCicero
Scope
National
Participating Institutions
Northside Hospital Diagnostic Clinic
Drugs Involved
Trastuzumab

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or